Search research articles
Contact Us
Filters
Showing results (71-80 of 145) with videos related to
Page
of 15
Sort By:
Cancer Research
|
January 1, 1994
Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts
R D Blumenthal, R M Sharkey, A M Natale, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 1999
Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies
M E Juweid, C H Zhang, R D Blumenthal, et al.
Nuclear Medicine Communications
|
February 1, 1997
99Tcm-LL1: a potential new bone marrow imaging agent
M Juweid, R M Dunn, R M Sharkey, et al.
Leukemia
|
April 9, 2005
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody
R M Sharkey, H Karacay, C-H Chang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 31, 1998
Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations
N Reddy, G L Ong, T M Behr, et al.
International Journal of Cancer
|
May 8, 1992
Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice
R M Sharkey, O C Boerman, A Natale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments
T M Behr, R D Blumenthal, S Memtsoudis, et al.
Cancer Research
|
November 1, 1987
Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen
R M Sharkey, M J Pykett, J A Siegel, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1992
Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor
O C Boerman, R M Sharkey, G Y Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1996
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2
M E Juweid, R M Sharkey, T Behr, et al.
Page
of 15
Search research articles
Search
Showing results (71-80 of 145) with videos related to
Sort By:
Page
of 15
Cancer Research
|
January 1, 1994
Comparison of equitoxic radioimmunotherapy and chemotherapy in the treatment of human colonic cancer xenografts
R D Blumenthal, R M Sharkey, A M Natale, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 1999
Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies
M E Juweid, C H Zhang, R D Blumenthal, et al.
Nuclear Medicine Communications
|
February 1, 1997
99Tcm-LL1: a potential new bone marrow imaging agent
M Juweid, R M Dunn, R M Sharkey, et al.
Leukemia
|
April 9, 2005
Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody
R M Sharkey, H Karacay, C-H Chang, et al.
Cancer Immunology, Immunotherapy : CII
|
March 31, 1998
Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations
N Reddy, G L Ong, T M Behr, et al.
International Journal of Cancer
|
May 8, 1992
Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice
R M Sharkey, O C Boerman, A Natale, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments
T M Behr, R D Blumenthal, S Memtsoudis, et al.
Cancer Research
|
November 1, 1987
Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen
R M Sharkey, M J Pykett, J A Siegel, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1992
Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor
O C Boerman, R M Sharkey, G Y Wong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 1, 1996
Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2
M E Juweid, R M Sharkey, T Behr, et al.
Page
of 15